Showing results (721-730 of 1,376) with videos related to

Sort By:
Pageof 138
Neuro-Oncology Advances|October 16, 2020
Clinical and molecular characterization of a multi-institutional cohort of pediatric spinal cord low-grade gliomasSydney T Grob, Liana Nobre, Kristen R Campbell, et al.
Neuro-Oncology Advances|June 6, 2022
Rare central nervous system tumors in adults: a population-based study of ependymomas, pilocytic astrocytomas, medulloblastomas, and intracranial germ cell tumorsVincent K Y Ho, Anja J M M Gijtenbeek, Michiel Wagemakers, et al.
Neuro-Oncology Advances|June 6, 2022
Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic dataJordan R Hansford, Jie Huang, Raelene Endersby, et al.
Neuro-Oncology Advances|June 23, 2022
Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline gliomaAimée du Chatinier, Michaël H Meel, Arvid I Das, et al.
Neuro-Oncology Advances|June 23, 2022
Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children's Oncology Group phase I consortium studySabine Mueller, Tabitha Cooney, Xiaodong Yang, et al.
Neuro-Oncology Advances|June 15, 2022
Pleiotropic MLLT10 variation confers risk of meningioma and estrogen-mediated cancersKyle M Walsh, Chenan Zhang, Lisa Calvocoressi, et al.
Neuro-Oncology Advances|May 31, 2021
Timing of glioblastoma surgery and patient outcomes: a multicenter cohort studyDomenique M J Müller, Merijn E De Swart, Hilko Ardon, et al.
Neuro-Oncology Advances|May 27, 2021
Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 2 recurrent glioblastomaShervin Taslimi, Vincent C Ye, Patrick Y Wen, et al.
Neuro-Oncology Advances|February 4, 2022
Neutrophil depletion enhanced the Clostridium novyi-NT therapy in mouse and rabbit tumor modelsVerena Staedtke, Tyler Gray-Bethke, Guanshu Liu, et al.
Neuro-Oncology Advances|February 4, 2022
Long-term effectiveness of Gliadel implant for malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in JapanToshihiko Iuchi, Akihiro Inoue, Yuichi Hirose, et al.
Pageof 138